1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Imatinib Mesylate API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Imatinib Mesylate API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Imatinib Mesylate API by Country/Region, 2018, 2022 & 2029
2.2 Imatinib Mesylate API Segment by Type
2.2.1 Purity≥99%
2.2.2 Purity<99%
2.3 Imatinib Mesylate API Sales by Type
2.3.1 Global Imatinib Mesylate API Sales Market Share by Type (2018-2023)
2.3.2 Global Imatinib Mesylate API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Imatinib Mesylate API Sale Price by Type (2018-2023)
2.4 Imatinib Mesylate API Segment by Application
2.4.1 Tablet
2.4.2 Capsule
2.5 Imatinib Mesylate API Sales by Application
2.5.1 Global Imatinib Mesylate API Sale Market Share by Application (2018-2023)
2.5.2 Global Imatinib Mesylate API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Imatinib Mesylate API Sale Price by Application (2018-2023)
3 Global Imatinib Mesylate API by Company
3.1 Global Imatinib Mesylate API Breakdown Data by Company
3.1.1 Global Imatinib Mesylate API Annual Sales by Company (2018-2023)
3.1.2 Global Imatinib Mesylate API Sales Market Share by Company (2018-2023)
3.2 Global Imatinib Mesylate API Annual Revenue by Company (2018-2023)
3.2.1 Global Imatinib Mesylate API Revenue by Company (2018-2023)
3.2.2 Global Imatinib Mesylate API Revenue Market Share by Company (2018-2023)
3.3 Global Imatinib Mesylate API Sale Price by Company
3.4 Key Manufacturers Imatinib Mesylate API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Imatinib Mesylate API Product Location Distribution
3.4.2 Players Imatinib Mesylate API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Imatinib Mesylate API by Geographic Region
4.1 World Historic Imatinib Mesylate API Market Size by Geographic Region (2018-2023)
4.1.1 Global Imatinib Mesylate API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Imatinib Mesylate API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Imatinib Mesylate API Market Size by Country/Region (2018-2023)
4.2.1 Global Imatinib Mesylate API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Imatinib Mesylate API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Imatinib Mesylate API Sales Growth
4.4 APAC Imatinib Mesylate API Sales Growth
4.5 Europe Imatinib Mesylate API Sales Growth
4.6 Middle East & Africa Imatinib Mesylate API Sales Growth
5 Americas
5.1 Americas Imatinib Mesylate API Sales by Country
5.1.1 Americas Imatinib Mesylate API Sales by Country (2018-2023)
5.1.2 Americas Imatinib Mesylate API Revenue by Country (2018-2023)
5.2 Americas Imatinib Mesylate API Sales by Type
5.3 Americas Imatinib Mesylate API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Imatinib Mesylate API Sales by Region
6.1.1 APAC Imatinib Mesylate API Sales by Region (2018-2023)
6.1.2 APAC Imatinib Mesylate API Revenue by Region (2018-2023)
6.2 APAC Imatinib Mesylate API Sales by Type
6.3 APAC Imatinib Mesylate API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Imatinib Mesylate API by Country
7.1.1 Europe Imatinib Mesylate API Sales by Country (2018-2023)
7.1.2 Europe Imatinib Mesylate API Revenue by Country (2018-2023)
7.2 Europe Imatinib Mesylate API Sales by Type
7.3 Europe Imatinib Mesylate API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Imatinib Mesylate API by Country
8.1.1 Middle East & Africa Imatinib Mesylate API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Imatinib Mesylate API Revenue by Country (2018-2023)
8.2 Middle East & Africa Imatinib Mesylate API Sales by Type
8.3 Middle East & Africa Imatinib Mesylate API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Imatinib Mesylate API
10.3 Manufacturing Process Analysis of Imatinib Mesylate API
10.4 Industry Chain Structure of Imatinib Mesylate API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Imatinib Mesylate API Distributors
11.3 Imatinib Mesylate API Customer
12 World Forecast Review for Imatinib Mesylate API by Geographic Region
12.1 Global Imatinib Mesylate API Market Size Forecast by Region
12.1.1 Global Imatinib Mesylate API Forecast by Region (2024-2029)
12.1.2 Global Imatinib Mesylate API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Imatinib Mesylate API Forecast by Type
12.7 Global Imatinib Mesylate API Forecast by Application
13 Key Players Analysis
13.1 Aurobindo Pharma Ltd
13.1.1 Aurobindo Pharma Ltd Company Information
13.1.2 Aurobindo Pharma Ltd Imatinib Mesylate API Product Portfolios and Specifications
13.1.3 Aurobindo Pharma Ltd Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Aurobindo Pharma Ltd Main Business Overview
13.1.5 Aurobindo Pharma Ltd Latest Developments
13.2 Formosa Laboratories Inc
13.2.1 Formosa Laboratories Inc Company Information
13.2.2 Formosa Laboratories Inc Imatinib Mesylate API Product Portfolios and Specifications
13.2.3 Formosa Laboratories Inc Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Formosa Laboratories Inc Main Business Overview
13.2.5 Formosa Laboratories Inc Latest Developments
13.3 Cadila Healthcare Ltd
13.3.1 Cadila Healthcare Ltd Company Information
13.3.2 Cadila Healthcare Ltd Imatinib Mesylate API Product Portfolios and Specifications
13.3.3 Cadila Healthcare Ltd Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Cadila Healthcare Ltd Main Business Overview
13.3.5 Cadila Healthcare Ltd Latest Developments
13.4 Laurus Labs Ltd
13.4.1 Laurus Labs Ltd Company Information
13.4.2 Laurus Labs Ltd Imatinib Mesylate API Product Portfolios and Specifications
13.4.3 Laurus Labs Ltd Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Laurus Labs Ltd Main Business Overview
13.4.5 Laurus Labs Ltd Latest Developments
13.5 Msn Laboratories Private Ltd
13.5.1 Msn Laboratories Private Ltd Company Information
13.5.2 Msn Laboratories Private Ltd Imatinib Mesylate API Product Portfolios and Specifications
13.5.3 Msn Laboratories Private Ltd Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Msn Laboratories Private Ltd Main Business Overview
13.5.5 Msn Laboratories Private Ltd Latest Developments
13.6 Intas Pharmaceuticals Ltd
13.6.1 Intas Pharmaceuticals Ltd Company Information
13.6.2 Intas Pharmaceuticals Ltd Imatinib Mesylate API Product Portfolios and Specifications
13.6.3 Intas Pharmaceuticals Ltd Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Intas Pharmaceuticals Ltd Main Business Overview
13.6.5 Intas Pharmaceuticals Ltd Latest Developments
13.7 Zydus Lifesciences Ltd
13.7.1 Zydus Lifesciences Ltd Company Information
13.7.2 Zydus Lifesciences Ltd Imatinib Mesylate API Product Portfolios and Specifications
13.7.3 Zydus Lifesciences Ltd Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Zydus Lifesciences Ltd Main Business Overview
13.7.5 Zydus Lifesciences Ltd Latest Developments
13.8 Hetero Labs Ltd
13.8.1 Hetero Labs Ltd Company Information
13.8.2 Hetero Labs Ltd Imatinib Mesylate API Product Portfolios and Specifications
13.8.3 Hetero Labs Ltd Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Hetero Labs Ltd Main Business Overview
13.8.5 Hetero Labs Ltd Latest Developments
13.9 Shilpa Pharma Lifesciences Ltd
13.9.1 Shilpa Pharma Lifesciences Ltd Company Information
13.9.2 Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Product Portfolios and Specifications
13.9.3 Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Shilpa Pharma Lifesciences Ltd Main Business Overview
13.9.5 Shilpa Pharma Lifesciences Ltd Latest Developments
13.10 Teva Pharmaceutical Industries Ltd
13.10.1 Teva Pharmaceutical Industries Ltd Company Information
13.10.2 Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Product Portfolios and Specifications
13.10.3 Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.10.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.11 Cipla Ltd
13.11.1 Cipla Ltd Company Information
13.11.2 Cipla Ltd Imatinib Mesylate API Product Portfolios and Specifications
13.11.3 Cipla Ltd Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Cipla Ltd Main Business Overview
13.11.5 Cipla Ltd Latest Developments
13.12 Acebright India Pharma Private Ltd
13.12.1 Acebright India Pharma Private Ltd Company Information
13.12.2 Acebright India Pharma Private Ltd Imatinib Mesylate API Product Portfolios and Specifications
13.12.3 Acebright India Pharma Private Ltd Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Acebright India Pharma Private Ltd Main Business Overview
13.12.5 Acebright India Pharma Private Ltd Latest Developments
13.13 Fis Fabbrica Italiana Sintetici Spa
13.13.1 Fis Fabbrica Italiana Sintetici Spa Company Information
13.13.2 Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Product Portfolios and Specifications
13.13.3 Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Fis Fabbrica Italiana Sintetici Spa Main Business Overview
13.13.5 Fis Fabbrica Italiana Sintetici Spa Latest Developments
13.14 Dr Reddys Laboratories Ltd
13.14.1 Dr Reddys Laboratories Ltd Company Information
13.14.2 Dr Reddys Laboratories Ltd Imatinib Mesylate API Product Portfolios and Specifications
13.14.3 Dr Reddys Laboratories Ltd Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Dr Reddys Laboratories Ltd Main Business Overview
13.14.5 Dr Reddys Laboratories Ltd Latest Developments
13.15 Natco Pharma Ltd
13.15.1 Natco Pharma Ltd Company Information
13.15.2 Natco Pharma Ltd Imatinib Mesylate API Product Portfolios and Specifications
13.15.3 Natco Pharma Ltd Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Natco Pharma Ltd Main Business Overview
13.15.5 Natco Pharma Ltd Latest Developments
13.16 Sun Pharmaceutical Industries Ltd
13.16.1 Sun Pharmaceutical Industries Ltd Company Information
13.16.2 Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Product Portfolios and Specifications
13.16.3 Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Sun Pharmaceutical Industries Ltd Main Business Overview
13.16.5 Sun Pharmaceutical Industries Ltd Latest Developments
13.17 Reliance Life Sciences Pvt Ltd
13.17.1 Reliance Life Sciences Pvt Ltd Company Information
13.17.2 Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Product Portfolios and Specifications
13.17.3 Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Reliance Life Sciences Pvt Ltd Main Business Overview
13.17.5 Reliance Life Sciences Pvt Ltd Latest Developments
13.18 Zhejiang Jiuzhou Pharmaceutical Co Ltd
13.18.1 Zhejiang Jiuzhou Pharmaceutical Co Ltd Company Information
13.18.2 Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Product Portfolios and Specifications
13.18.3 Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Zhejiang Jiuzhou Pharmaceutical Co Ltd Main Business Overview
13.18.5 Zhejiang Jiuzhou Pharmaceutical Co Ltd Latest Developments
13.19 Tai Heng Industry Group Co Ltd
13.19.1 Tai Heng Industry Group Co Ltd Company Information
13.19.2 Tai Heng Industry Group Co Ltd Imatinib Mesylate API Product Portfolios and Specifications
13.19.3 Tai Heng Industry Group Co Ltd Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Tai Heng Industry Group Co Ltd Main Business Overview
13.19.5 Tai Heng Industry Group Co Ltd Latest Developments
13.20 Shandong Anxin Pharmaceutical Co Ltd
13.20.1 Shandong Anxin Pharmaceutical Co Ltd Company Information
13.20.2 Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Product Portfolios and Specifications
13.20.3 Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Shandong Anxin Pharmaceutical Co Ltd Main Business Overview
13.20.5 Shandong Anxin Pharmaceutical Co Ltd Latest Developments
14 Research Findings and Conclusion
Table 1. Imatinib Mesylate API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Imatinib Mesylate API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity≥99%
Table 4. Major Players of Purity<99%
Table 5. Global Imatinib Mesylate API Sales by Type (2018-2023) & (Tons)
Table 6. Global Imatinib Mesylate API Sales Market Share by Type (2018-2023)
Table 7. Global Imatinib Mesylate API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Imatinib Mesylate API Revenue Market Share by Type (2018-2023)
Table 9. Global Imatinib Mesylate API Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Imatinib Mesylate API Sales by Application (2018-2023) & (Tons)
Table 11. Global Imatinib Mesylate API Sales Market Share by Application (2018-2023)
Table 12. Global Imatinib Mesylate API Revenue by Application (2018-2023)
Table 13. Global Imatinib Mesylate API Revenue Market Share by Application (2018-2023)
Table 14. Global Imatinib Mesylate API Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Imatinib Mesylate API Sales by Company (2018-2023) & (Tons)
Table 16. Global Imatinib Mesylate API Sales Market Share by Company (2018-2023)
Table 17. Global Imatinib Mesylate API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Imatinib Mesylate API Revenue Market Share by Company (2018-2023)
Table 19. Global Imatinib Mesylate API Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Imatinib Mesylate API Producing Area Distribution and Sales Area
Table 21. Players Imatinib Mesylate API Products Offered
Table 22. Imatinib Mesylate API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Imatinib Mesylate API Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Imatinib Mesylate API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Imatinib Mesylate API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Imatinib Mesylate API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Imatinib Mesylate API Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Imatinib Mesylate API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Imatinib Mesylate API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Imatinib Mesylate API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Imatinib Mesylate API Sales by Country (2018-2023) & (Tons)
Table 34. Americas Imatinib Mesylate API Sales Market Share by Country (2018-2023)
Table 35. Americas Imatinib Mesylate API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Imatinib Mesylate API Revenue Market Share by Country (2018-2023)
Table 37. Americas Imatinib Mesylate API Sales by Type (2018-2023) & (Tons)
Table 38. Americas Imatinib Mesylate API Sales by Application (2018-2023) & (Tons)
Table 39. APAC Imatinib Mesylate API Sales by Region (2018-2023) & (Tons)
Table 40. APAC Imatinib Mesylate API Sales Market Share by Region (2018-2023)
Table 41. APAC Imatinib Mesylate API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Imatinib Mesylate API Revenue Market Share by Region (2018-2023)
Table 43. APAC Imatinib Mesylate API Sales by Type (2018-2023) & (Tons)
Table 44. APAC Imatinib Mesylate API Sales by Application (2018-2023) & (Tons)
Table 45. Europe Imatinib Mesylate API Sales by Country (2018-2023) & (Tons)
Table 46. Europe Imatinib Mesylate API Sales Market Share by Country (2018-2023)
Table 47. Europe Imatinib Mesylate API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Imatinib Mesylate API Revenue Market Share by Country (2018-2023)
Table 49. Europe Imatinib Mesylate API Sales by Type (2018-2023) & (Tons)
Table 50. Europe Imatinib Mesylate API Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Imatinib Mesylate API Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Imatinib Mesylate API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Imatinib Mesylate API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Imatinib Mesylate API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Imatinib Mesylate API Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Imatinib Mesylate API Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Imatinib Mesylate API
Table 58. Key Market Challenges & Risks of Imatinib Mesylate API
Table 59. Key Industry Trends of Imatinib Mesylate API
Table 60. Imatinib Mesylate API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Imatinib Mesylate API Distributors List
Table 63. Imatinib Mesylate API Customer List
Table 64. Global Imatinib Mesylate API Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Imatinib Mesylate API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Imatinib Mesylate API Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Imatinib Mesylate API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Imatinib Mesylate API Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Imatinib Mesylate API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Imatinib Mesylate API Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Imatinib Mesylate API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Imatinib Mesylate API Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Imatinib Mesylate API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Imatinib Mesylate API Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Imatinib Mesylate API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Imatinib Mesylate API Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Imatinib Mesylate API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Aurobindo Pharma Ltd Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 79. Aurobindo Pharma Ltd Imatinib Mesylate API Product Portfolios and Specifications
Table 80. Aurobindo Pharma Ltd Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Aurobindo Pharma Ltd Main Business
Table 82. Aurobindo Pharma Ltd Latest Developments
Table 83. Formosa Laboratories Inc Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 84. Formosa Laboratories Inc Imatinib Mesylate API Product Portfolios and Specifications
Table 85. Formosa Laboratories Inc Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Formosa Laboratories Inc Main Business
Table 87. Formosa Laboratories Inc Latest Developments
Table 88. Cadila Healthcare Ltd Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 89. Cadila Healthcare Ltd Imatinib Mesylate API Product Portfolios and Specifications
Table 90. Cadila Healthcare Ltd Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Cadila Healthcare Ltd Main Business
Table 92. Cadila Healthcare Ltd Latest Developments
Table 93. Laurus Labs Ltd Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 94. Laurus Labs Ltd Imatinib Mesylate API Product Portfolios and Specifications
Table 95. Laurus Labs Ltd Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Laurus Labs Ltd Main Business
Table 97. Laurus Labs Ltd Latest Developments
Table 98. Msn Laboratories Private Ltd Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 99. Msn Laboratories Private Ltd Imatinib Mesylate API Product Portfolios and Specifications
Table 100. Msn Laboratories Private Ltd Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Msn Laboratories Private Ltd Main Business
Table 102. Msn Laboratories Private Ltd Latest Developments
Table 103. Intas Pharmaceuticals Ltd Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 104. Intas Pharmaceuticals Ltd Imatinib Mesylate API Product Portfolios and Specifications
Table 105. Intas Pharmaceuticals Ltd Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Intas Pharmaceuticals Ltd Main Business
Table 107. Intas Pharmaceuticals Ltd Latest Developments
Table 108. Zydus Lifesciences Ltd Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 109. Zydus Lifesciences Ltd Imatinib Mesylate API Product Portfolios and Specifications
Table 110. Zydus Lifesciences Ltd Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. Zydus Lifesciences Ltd Main Business
Table 112. Zydus Lifesciences Ltd Latest Developments
Table 113. Hetero Labs Ltd Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 114. Hetero Labs Ltd Imatinib Mesylate API Product Portfolios and Specifications
Table 115. Hetero Labs Ltd Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Hetero Labs Ltd Main Business
Table 117. Hetero Labs Ltd Latest Developments
Table 118. Shilpa Pharma Lifesciences Ltd Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 119. Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Product Portfolios and Specifications
Table 120. Shilpa Pharma Lifesciences Ltd Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Shilpa Pharma Lifesciences Ltd Main Business
Table 122. Shilpa Pharma Lifesciences Ltd Latest Developments
Table 123. Teva Pharmaceutical Industries Ltd Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 124. Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Product Portfolios and Specifications
Table 125. Teva Pharmaceutical Industries Ltd Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Teva Pharmaceutical Industries Ltd Main Business
Table 127. Teva Pharmaceutical Industries Ltd Latest Developments
Table 128. Cipla Ltd Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 129. Cipla Ltd Imatinib Mesylate API Product Portfolios and Specifications
Table 130. Cipla Ltd Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 131. Cipla Ltd Main Business
Table 132. Cipla Ltd Latest Developments
Table 133. Acebright India Pharma Private Ltd Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 134. Acebright India Pharma Private Ltd Imatinib Mesylate API Product Portfolios and Specifications
Table 135. Acebright India Pharma Private Ltd Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 136. Acebright India Pharma Private Ltd Main Business
Table 137. Acebright India Pharma Private Ltd Latest Developments
Table 138. Fis Fabbrica Italiana Sintetici Spa Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 139. Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Product Portfolios and Specifications
Table 140. Fis Fabbrica Italiana Sintetici Spa Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 141. Fis Fabbrica Italiana Sintetici Spa Main Business
Table 142. Fis Fabbrica Italiana Sintetici Spa Latest Developments
Table 143. Dr Reddys Laboratories Ltd Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 144. Dr Reddys Laboratories Ltd Imatinib Mesylate API Product Portfolios and Specifications
Table 145. Dr Reddys Laboratories Ltd Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 146. Dr Reddys Laboratories Ltd Main Business
Table 147. Dr Reddys Laboratories Ltd Latest Developments
Table 148. Natco Pharma Ltd Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 149. Natco Pharma Ltd Imatinib Mesylate API Product Portfolios and Specifications
Table 150. Natco Pharma Ltd Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 151. Natco Pharma Ltd Main Business
Table 152. Natco Pharma Ltd Latest Developments
Table 153. Sun Pharmaceutical Industries Ltd Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 154. Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Product Portfolios and Specifications
Table 155. Sun Pharmaceutical Industries Ltd Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 156. Sun Pharmaceutical Industries Ltd Main Business
Table 157. Sun Pharmaceutical Industries Ltd Latest Developments
Table 158. Reliance Life Sciences Pvt Ltd Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 159. Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Product Portfolios and Specifications
Table 160. Reliance Life Sciences Pvt Ltd Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 161. Reliance Life Sciences Pvt Ltd Main Business
Table 162. Reliance Life Sciences Pvt Ltd Latest Developments
Table 163. Zhejiang Jiuzhou Pharmaceutical Co Ltd Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 164. Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Product Portfolios and Specifications
Table 165. Zhejiang Jiuzhou Pharmaceutical Co Ltd Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 166. Zhejiang Jiuzhou Pharmaceutical Co Ltd Main Business
Table 167. Zhejiang Jiuzhou Pharmaceutical Co Ltd Latest Developments
Table 168. Tai Heng Industry Group Co Ltd Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 169. Tai Heng Industry Group Co Ltd Imatinib Mesylate API Product Portfolios and Specifications
Table 170. Tai Heng Industry Group Co Ltd Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 171. Tai Heng Industry Group Co Ltd Main Business
Table 172. Tai Heng Industry Group Co Ltd Latest Developments
Table 173. Shandong Anxin Pharmaceutical Co Ltd Basic Information, Imatinib Mesylate API Manufacturing Base, Sales Area and Its Competitors
Table 174. Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Product Portfolios and Specifications
Table 175. Shandong Anxin Pharmaceutical Co Ltd Imatinib Mesylate API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 176. Shandong Anxin Pharmaceutical Co Ltd Main Business
Table 177. Shandong Anxin Pharmaceutical Co Ltd Latest Developments
List of Figures
Figure 1. Picture of Imatinib Mesylate API
Figure 2. Imatinib Mesylate API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Imatinib Mesylate API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Imatinib Mesylate API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Imatinib Mesylate API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity≥99%
Figure 10. Product Picture of Purity<99%
Figure 11. Global Imatinib Mesylate API Sales Market Share by Type in 2022
Figure 12. Global Imatinib Mesylate API Revenue Market Share by Type (2018-2023)
Figure 13. Imatinib Mesylate API Consumed in Tablet
Figure 14. Global Imatinib Mesylate API Market: Tablet (2018-2023) & (Tons)
Figure 15. Imatinib Mesylate API Consumed in Capsule
Figure 16. Global Imatinib Mesylate API Market: Capsule (2018-2023) & (Tons)
Figure 17. Global Imatinib Mesylate API Sales Market Share by Application (2022)
Figure 18. Global Imatinib Mesylate API Revenue Market Share by Application in 2022
Figure 19. Imatinib Mesylate API Sales Market by Company in 2022 (Tons)
Figure 20. Global Imatinib Mesylate API Sales Market Share by Company in 2022
Figure 21. Imatinib Mesylate API Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Imatinib Mesylate API Revenue Market Share by Company in 2022
Figure 23. Global Imatinib Mesylate API Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Imatinib Mesylate API Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Imatinib Mesylate API Sales 2018-2023 (Tons)
Figure 26. Americas Imatinib Mesylate API Revenue 2018-2023 ($ Millions)
Figure 27. APAC Imatinib Mesylate API Sales 2018-2023 (Tons)
Figure 28. APAC Imatinib Mesylate API Revenue 2018-2023 ($ Millions)
Figure 29. Europe Imatinib Mesylate API Sales 2018-2023 (Tons)
Figure 30. Europe Imatinib Mesylate API Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Imatinib Mesylate API Sales 2018-2023 (Tons)
Figure 32. Middle East & Africa Imatinib Mesylate API Revenue 2018-2023 ($ Millions)
Figure 33. Americas Imatinib Mesylate API Sales Market Share by Country in 2022
Figure 34. Americas Imatinib Mesylate API Revenue Market Share by Country in 2022
Figure 35. Americas Imatinib Mesylate API Sales Market Share by Type (2018-2023)
Figure 36. Americas Imatinib Mesylate API Sales Market Share by Application (2018-2023)
Figure 37. United States Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Imatinib Mesylate API Sales Market Share by Region in 2022
Figure 42. APAC Imatinib Mesylate API Revenue Market Share by Regions in 2022
Figure 43. APAC Imatinib Mesylate API Sales Market Share by Type (2018-2023)
Figure 44. APAC Imatinib Mesylate API Sales Market Share by Application (2018-2023)
Figure 45. China Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Imatinib Mesylate API Sales Market Share by Country in 2022
Figure 53. Europe Imatinib Mesylate API Revenue Market Share by Country in 2022
Figure 54. Europe Imatinib Mesylate API Sales Market Share by Type (2018-2023)
Figure 55. Europe Imatinib Mesylate API Sales Market Share by Application (2018-2023)
Figure 56. Germany Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Imatinib Mesylate API Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Imatinib Mesylate API Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Imatinib Mesylate API Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Imatinib Mesylate API Sales Market Share by Application (2018-2023)
Figure 65. Egypt Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Imatinib Mesylate API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Imatinib Mesylate API in 2022
Figure 71. Manufacturing Process Analysis of Imatinib Mesylate API
Figure 72. Industry Chain Structure of Imatinib Mesylate API
Figure 73. Channels of Distribution
Figure 74. Global Imatinib Mesylate API Sales Market Forecast by Region (2024-2029)
Figure 75. Global Imatinib Mesylate API Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Imatinib Mesylate API Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Imatinib Mesylate API Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Imatinib Mesylate API Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Imatinib Mesylate API Revenue Market Share Forecast by Application (2024-2029)
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
